Re-engineered TAmiRNA website goes live
Press Release | TAmiRNA GmbH
JANUARY 07, 2020
The new website went ‘live’ in early December, including key changes to navigation, with pull down contextual menus allowing customers easier access to key information about TAmiRNA one-stop biomarker development services of diagnostic solutions for early diagnosis, prognosis, or patient stratification.
The site has also been engineered for easier mobile browsing from tablet or smartphone.
The website now provides more information and ordering functionality for TAmiRNA products, notably the thrombomiR® kit, which provides an in vivo measure of platelet function independent of the activation pathway or the osteomiR™ kit, enabling rapid detection of microRNAs that can serve as novel validated bone biomarkers for early diagnosis and prognosis of fracture risk in post-menopausal osteoporosis and bone quality.
It also provides useful information resources on various aspects of microRNAs, including function & biogenesis, biomarker applications, osteoporosis diagnosis and risk reductions, platelet functions and toxicity.
“We have redesigned the site bearing in mind the needs of biotech and pharma companies participating in clinical studies, universities, clinical research groups, potential customers and partners,” commented TAmiRNA head of Scientific Communications, Dr. Elisabeth Semmelrock, who was a key member of the site development team.
“We have widely publicized the new site to our customers by email and to our social media followers and initial feedback has been very favorable,’ said Dr. Semmelrock.
TAmiRNA specializes in technologies for profiling levels of blood-circulating microRNAs and developing multi-parametric classification algorithms (“signatures”). TAmiRNA uses these technologies to develop minimal-invasive diagnostic tests for drug development, early diagnosis and prognosis of disease, and as companion diagnostic tests to support treatment decisions.
Dr. Elisabeth Semmelrock, Scientific Communications, TAmiRNA GmbH
Tel: +43 1 391 33 22 90